```html

Yellow Eyes (Jaundice): A Complete Medical Guide

Overview

Jaundice is the yellow discoloration of the skin, sclera (the white part of the eyes), and mucous membranes caused by an excess of bilirubin in the bloodstream. Although “yellow eyes” is often the first sign that patients notice, jaundice is a systemic finding that reflects an underlying problem with bilirubin production, transport, metabolism, or excretion.

Who it affects: Jaundice can occur at any age—from newborns to older adults. In infants, it is extremely common (affecting up to 60 % of term babies in the first week of life). In adults, prevalence varies with the underlying disease: chronic liver disease affects an estimated 1.8 % of the U.S. population, while hemolytic anemias affect <1 % but are a leading cause of acute jaundice.

Global burden: According to the World Health Organization (WHO), liver disease—including viral hepatitis, alcoholic liver disease, and non‑alcoholic fatty liver disease (NAFL‑FLD)—accounts for more than 2 % of all deaths worldwide, many of which present with jaundice as a symptom.

Symptoms

Jaundice itself is a symptom rather than a disease. The following signs and symptoms may accompany yellow eyes, depending on the cause:

• Yellow discoloration of the sclera: Often the earliest and most noticeable sign.
• Yellow skin: Starts on the face and neck, spreading to the trunk and limbs.
• Dark urine: Bilirubin excreted by the kidneys gives urine a tea‑color.
• Pale stools: Lack of bile pigments makes stools clay‑colored.
• Itching (pruritus): Bile salts deposited in the skin can cause intense scratching.
• Fatigue and weakness: Common in chronic liver disease.
• Right upper‑quadrant abdominal pain: May indicate gallbladder or liver pathology.
• Weight loss, loss of appetite: Seen with malignancy or advanced liver disease.
• Fever and chills: Suggest an infectious cause such as cholangitis.
• Swelling of the abdomen (ascites) or legs (edema): Indicates portal hypertension or severe liver dysfunction.
• Confusion or altered mental status (hepatic encephalopathy): A serious complication of liver failure.

Causes and Risk Factors

Jaundice arises when the balance between bilirubin production and elimination is disturbed. The causes are traditionally grouped into three categories:

Pre‑Hepatic (Hemolytic) Causes

• Hereditary spherocytosis, G6PD deficiency, sickle‑cell disease
• Autoimmune hemolytic anemia
• Mechanical destruction of red blood cells (e.g., from prosthetic heart valves)
• Severe infections (malaria, sepsis)

Hepatic Causes (Impaired Processing)

• Viral hepatitis (A, B, C, D, E)
• Alcoholic liver disease
• Non‑alcoholic fatty liver disease (NAFL‑FLD) – affects ~25 % of U.S. adults
• Cirrhosis from any etiology
• Drug‑induced liver injury (acetaminophen overdose, certain antibiotics, anticonvulsants)
• Genetic metabolic disorders (Gilbert’s syndrome, Crigler‑Najjar syndrome)
• Liver cancer (hepatocellular carcinoma, metastases)

Post‑Hepatic (Obstructive) Causes

• Gallstones blocking the common bile duct
• Pancreatic head tumor (pancreatic adenocarcinoma)
• Strictures or cholangiocarcinoma of the bile ducts
• Parasites (Clonorchis sinensis, Opisthorchis viverrini)
• Post‑surgical bile duct injury

Risk Factors

• Heavy alcohol consumption (>14 drinks/week for men, >7 drinks/week for women)
• Chronic viral hepatitis infection
• Obesity and type 2 diabetes (major risk for NAFL‑FLD)
• Family history of hereditary hemolytic disorders
• Use of hepatotoxic medications or herbal supplements
• Previous biliary surgery or endoscopic procedures

Diagnosis

Evaluation of jaundice aims to identify the underlying mechanism and severity.

History and Physical Examination

• Ask about onset, progression, associated symptoms, medication use, alcohol intake, travel, and family history.
• Physical exam focuses on scleral color, skin tone, abdominal tenderness, hepatomegaly, splenomegaly, and presence of ascites.

Laboratory Tests

Test	What it Shows
Serum bilirubin (total & direct)	Elevated >2.5 mg/dL confirms jaundice; direct vs indirect helps locate cause.
Complete blood count (CBC)	Hemolysis – low hemoglobin, high reticulocyte count.
Liver enzymes (ALT, AST, ALP, GGT)	ALT/AST ↑ → hepatocellular injury; ALP/GGT ↑ → cholestasis.
Prothrombin time/INR	Liver synthetic function.
Serum albumin	Chronic liver disease marker.
Viral hepatitis serologies	Identify acute or chronic infection.
Autoimmune markers (ANA, ASMA, LKM‑1)	Autoimmune hepatitis.
Hemolysis panel (LDH, haptoglobin, peripheral smear)	Supports pre‑hepatic cause.

Imaging Studies

• Ultrasound: First‑line for detecting gallstones, biliary duct dilation, liver texture.
• CT or MRI: Detailed evaluation of masses, pancreatic tumors, or complex biliary anatomy.
• MRCP (magnetic resonance cholangiopancreatography): Non‑invasive view of bile ducts.
• Endoscopic ultrasound (EUS) or ERCP: Diagnostic and therapeutic for obstructive disease.

Other Specialized Tests

• Genetic testing for Gilbert’s or Crigler‑Najjar syndromes.
• Liver biopsy (percutaneous or trans‑jugular) when diagnosis remains uncertain or to stage fibrosis.

Treatment Options

Treatment is directed at the underlying cause; supportive care addresses the bilirubin excess.

General Measures

• Maintain adequate hydration—helps renal excretion of bilirubin.
• Nutrition: high‑protein, low‑fat diet unless contraindicated by ascites.
• Phototherapy (blue‑light) for severe neonatal jaundice.

Specific Therapies

Pre‑Hepatic (Hemolytic) Jaundice

• Treat underlying hemolysis: steroids for autoimmune hemolytic anemia, hydroxyurea for sickle‑cell disease, cessation of offending drugs.
• Folic acid supplementation to support red‑cell production.
• Exchange transfusion for severe neonatal hemolysis.

Hepatic Jaundice

• Viral hepatitis: Antiviral agents (e.g., entecavir, tenofovir for HBV; direct‑acting antivirals for HCV).
• Alcoholic liver disease: Abstinence, nutritional rehab, corticosteroids for severe alcoholic hepatitis.
• NAFL‑FLD: Weight loss of 7‑10 % body weight, exercise, control of diabetes and hyperlipidemia.
• Drug‑induced injury: Immediate discontinuation of the offending agent; N‑acetylcysteine for acetaminophen toxicity.
• Genetic disorders: Gilbert’s syndrome needs no treatment; severe Crigler‑Najjar may require liver transplantation.
• Liver cancer: Surgical resection, radiofrequency ablation, trans‑arterial chemoembolization (TACE), or systemic therapy.

Post‑Hepatic (Obstructive) Jaundice

• Endoscopic removal of common bile duct stones (ERCP with sphincterotomy).
• Stenting of malignant biliary obstruction.
• Surgical resection of pancreatic or cholangiocarcinomas when feasible.
• Antiparasitic therapy (praziquantel) for fluke infections.

Adjunctive Treatments

• Ursodeoxycholic acid (UDCA) for cholestatic diseases (primary biliary cholangitis, gallstone dissolution).
• Pruritus control: cholestyramine, rifampin, or naltrexone.
• Vitamin K supplementation if coagulopathy develops.

Living with Yellow Eyes (Jaundice)

Even after the acute cause is treated, many patients need ongoing management.

Daily Management Tips

• Monitor bilirubin levels: Follow-up labs as ordered; note any re‑darkening of eyes or skin.
• Skin care: Use mild soaps, moisturizers, and avoid hot water that can worsen itching.
• Dietary adjustments: Limit saturated fats, increase fiber, and stay within your caloric goals.
• Alcohol avoidance: Zero alcohol is recommended for most liver diseases.
• Medication safety: Keep a list of hepatotoxic drugs; discuss any new medication with your provider.
• Vaccinations: Hepatitis A and B vaccines protect against super‑infection.
• Physical activity: Aim for 150 minutes of moderate aerobic exercise per week, which improves liver fat content.
• Weight monitoring: A gradual weight loss of 0.5‑1 kg/week is safe and beneficial for NAFL‑FLD.

Psychosocial Support

Chronic liver disease can affect mood and quality of life. Consider counseling, support groups, or liver‑specific mental‑health resources. Many transplant centers offer peer‑mentor programs.

Prevention

Because jaundice signals an underlying problem, preventing the root cause is key.

• Vaccinate against hepatitis A and B; screen high‑risk individuals for hepatitis C.
• Practice safe sex and avoid sharing needles.
• Limit alcohol intake; follow guidelines for low‑risk drinking.
• Maintain a healthy weight; manage diabetes, hyperlipidemia, and hypertension.
• Use medications responsibly—follow dosing instructions, avoid unnecessary herbal supplements.
• Adopt safe food handling to prevent food‑borne parasites (e.g., cook fish thoroughly).
• For newborns, ensure proper prenatal care and early bilirubin screening; treat significant neonatal jaundice promptly.

Complications

If the underlying cause of jaundice is not addressed, serious complications can develop:

• Acute liver failure: Rapid loss of liver function, coagulopathy, encephalopathy—may require transplantation.
• Chronic liver disease & cirrhosc​osis: Portal hypertension, ascites, variceal bleeding.
• Hepatic encephalopathy: Cognitive impairment due to toxin accumulation.
• Sepsis: Especially in obstructive jaundice where bile stasis fosters bacterial growth.
• Kidney injury: Bilirubin nephropathy in severe hyperbilirubinemia.
• Pregnancy complications: Intra‑hepatic cholestasis of pregnancy can cause fetal distress.
• Increased mortality: Studies show that patients with persistent jaundice due to advanced liver disease have a 5‑year mortality >30 % (Mayo Clinic, 2022).

When to Seek Emergency Care

---

References:

1. Mayo Clinic. Jaundice: Symptoms & Causes. Accessed June 2024.
2. World Health Organization. Global Hepatitis Report 2023. WHO.
3. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Non‑Alcoholic Fatty Liver Disease. NIH.
4. Cleveland Clinic. Jaundice – Evaluation and Treatment. Cleveland Clinic.
5. American College of Gastroenterology. ACG Clinical Guideline: Management of Acute Liver Failure. 2022.
6. CDC. Hepatitis A & B Vaccines: Who Should Get Them. CDC.

```